Alendronate reduces adjacent-level vertebral fractures

Alendronate reduces adjacent-level vertebral fractures

(HealthDay)—For females with osteoporosis, the rate of adjacent-level vertebral fractures is relatively low, with reduced odds with bisphosphonate therapy, according to a study published in the Dec. 1 issue of Spine.

Bruce Frankel, M.D., from the Medical University of South Carolina in Charleston, and colleagues examined the risk of adjacent-level in patients with osteoporosis using data from a large, randomized fracture intervention trial of alendronate treatment. Incident morphometric fracture rates were assessed for bisphosphonate-treated and bisphosphonate-naive patients (1,950 participants).

During a mean follow-up of 2.9 years, the researchers identified adjacent-level vertebral fractures in 3.4 percent of patients in the alendronate group and 7.4 percent of patients in the placebo group, with annual rates of 1.2 and 2.5 percent, respectively. The thoracolumbar region (T11, T12, and L1) seemed to be the most prone to new adjacent-level fractures. In univariate analysis, at randomization, lower bone , inactivity, and placebo therapy correlated significantly with adjacent-level fractures (P ≤ 0.05). The odds of adjacent-level fractures were decreased with bisphosphonate therapy and higher bone mineral density, and were increased with older age at randomization, in multivariate analysis (P ≤ 0.05).

"New vertebral fractures adjacent to prevalent fractures occurred relatively infrequently in this treatment trial of alendronate in females with , and were more common with older age at randomization, lower and placebo treatment," the authors write.

Relevant financial activities outside the submitted work were disclosed: consultancy, grants, patents, royalties.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

The deadly news about all osteoporotic fractures

Nov 27, 2013

It is well known that hip and vertebral fractures increase the risk of premature death. Until now, little has been known about the clinical impact of non-hip, non-vertebral fractures – so new Australian research showing ...

Recommended for you

Sierra Leone streets deserted as shutdown begins

2 hours ago

Sierra Leone's normally chaotic capital resembled a ghost town on Friday as residents were confined to their homes for the start of a three-day lockdown aimed at halting the deadly Ebola epidemic.

Sierra Leone launches controversial Ebola shutdown

4 hours ago

Sierra Leone on Friday launched a controversial three-day shutdown to contain the deadly spread of the Ebola virus, as the UN Security Council declared the deadly outbreak a threat to world peace.

Cooling of dialysis fluids protects against brain damage

16 hours ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

17 hours ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments